medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 5

<< Back Next >>

Med Int Mex 2021; 37 (5)

Clinical experiences with Lactobacillus (2016-2019)

Rodríguez-Orozco AR, Quintero-Silva RY, Romero-Escobar RS, Garcés-Alanís MA, Talavera-Saucedo G, Querea-Vázquez J, Herrera-González Y

Language: Spanish
References: 87
Page: 738-758
PDF size: 332.89 Kb.


ABSTRACT

The use of Lactobacillus in the clinic is becoming more common. Because of their versatility and apparent safety, the use of these has diversified to treat patients with infectious diseases, irritable bowel syndrome, allergies and cancer. This article aims to review the state of art on the efficacy with the use of Lactobacillus in controlled clinical trials. Human clinical trials published between January 2016 and June 12, 2019 were reviewed at the MEDLINE database. A total of 348 articles were reviewed, of which those using mixtures with other probiotics other than Lactobacillus were discarded, resulting in a total of 74 articles. Among 74 articles reviewed, efficacy was statistically demonstrated in 74% of them.


REFERENCES

  1. Moreno del Castillo C, Valladares GJ, Halabe CJ. Microbioma humano. Rev Fac Med (Mex) 2018. 61(6): 7-19. https://doi. org/10.22201.fm.24484865e.2018.61.6.02.

  2. Organización Mundial de la Salud. Guía Práctica de la Organización Mundial de Gastroenterología: Probióticos y prebióticos. Guías Mundiales de WGO probióticos y prebióticos. 2017. http://www.worldgastroenterology. org/guidelines/globalguidelines/probioticsandprebiotics/ probiotics-and-prebiotics-spanish.

  3. Consulta de Expertos FAO/OMS sobre Evaluación de las Propiedades Saludables y Nutricionales de los Probióticos en los Alimentos, incluida la Leche en Polvo con Bacterias Vivas del Ácido Láctico Córdoba, Argentina, 1–4 de octubre de 2001. http://www.fao.org/3/a-a0512s.pdf.

  4. Goldstein EJ, Tyrrell KL, Citron DM. Lactobacillus species: taxonomic complexity and controversial susceptibilities. 2015; 60 (Suppl 2): S98-107. doi: 10.1093/cid/civ072.

  5. Viloche J, Tito C. Aislamiento de lactobacillus nativos de productos de fermentación en la ciudad de Tacna. cyd 2007; 11: 61-6. https://doi.org/10.33326/26176033.2007.11.226.

  6. Samaniego LM, Sosa del Castillo. Lactobacillus spp: Importantes promotores de actividad probiótica, antimicrobiana y bioconservadora. [Tesis]. Matanzas: Centro de Estudios Biotecnológicos, Facultad de Agronomía, Universidad de Matanzas; 2000.

  7. Zamudio K, Zavaleta A. Estudio del potencial probiótico de lactobacilos aislados de fuentes naturales. Ciencia Investigación 2003; 6 (1): 30-5. https://doi.org/10.15381/ ci.v6i1.3317.

  8. Cabezas MA. Evaluación de la Capacidad de Colonización Intestinal de un Lactobacillus spp Proveniente de un Fermento Comercial. [Tesis]. Quito: Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito; 2009.

  9. Ramírez JC, Ulloa P, Velázquez M, Ulloa J, Arce F. Bacterias lácticas: Importancia en alimentos y sus efectos en la salud. Rev Fuente 2011; 2 (7): 1-16.

  10. Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebocontrolled trial. J Pediatr 2016; 174: 160-164.e1. doi: 10.1016/j.jpeds.2016.04.003.

  11. Sobrino OJ. Caracterización parcial, bioquímica e inmunológica de una sustancia antimicrobiana producida por Lactobacillus sake 148. [Tesis doctoral]. Madrid: Departamento de Nutrición y Bromatología III (Higiene y Tecnología de los Alimentos), Facultad de Veterinaria, Universidad Complutense de Madrid; 1993.

  12. Roldán ML, Otero JL, Villarreal F, Baroni MR, Carrasco MS, Álvarez C y col. Efecto inhibidor de Lactobacillus casei 206/1 contra Escherichia coli O157:H7. Revista de la Sociedad Venezolana de Microbiología 2011; 31 (1): 37-41.

  13. Khalili L, Alipour B, Asghari Jafar-Abadi M, Faraji I, Hassanalilou T, Mesgari-Abbasi M, et al. The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-A levels in patients with type 2 diabetes mellitus: A randomized controlled trial. Iran Biomed J 2019; 23 (1): 68-77. doi: 10.29252/.23.1.68.

  14. Ishizaki A, Bi X, Nguyen L, Matsuda K, Pham H, Phan C, et al. Effects of short-term probiotic ingestion on immune profiles and microbial translocation among HIV-1-infected Vietnamese children. Int J Mol Sci 2017; 18 (10): 2185. doi: 10.3390/ijms18102185.

  15. Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: A randomised double-blind, placebo-controlled clinical trial. Benef Microbes 2017; 8 (5): 697-703. doi: 10.3920/ BM2016.0207.

  16. Nagata S, Chiba Y, Wang C, Yamashiro Y. The effects of the Lactobacillus casei strain on obesity in children: a pilot study. Benef Microbes 2017; 8 (4): 535-543. doi: 10.3920/ BM2016.0170.

  17. Takada M, Nishida K, Gondo Y, Kikuchi-Hayakawa H, Ishikawa H, Suda K, et al. Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Benef Microbes 2017; 8 (2): 153- 162. DOI:10.3920/BM2016.0150.

  18. Kleniewska P, Pawliczak R. Influence of synbiotics on selected oxidative stress parameters. Oxidative Medicine and Cellular Longevity 2017; 2017: 9315375. https://doi. org/10.1155/2017/9315375.

  19. Lee CY, Yu MC, Perng WT, Lin CC, Lee MY, Chang YL, et al. No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial. Clin J Integrative Med 2017; 23 (8): 581-588. https://doi.org/10.1007/s11655-016-2530-1.

  20. Lei M, Hua LM, Wang DW. The effect of probiotic treatment on elderly patients with distal radius fracture: a prospective double-blind, placebo-controlled randomised clinical trial. Benef Microbes 2016; 7 (5): 631-637. doi: 10.3920/ BM2016.0067.

  21. Kato-Kataoka A, Nishida K, Takada M, Kawai M, Kikuchi- Hayakawa H, Suda K, et al. Fermented milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl Environ Microbiol 2016; 82 (12): 3649-58. doi: 10.1128/ AEM.04134-15.

  22. Takada M, Nishida K, Kataoka-Kato A, Gondo Y, Ishikawa H, Suda K. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil 2016; 28 (7): 1027-36. doi: 10.1111/nmo.12804.

  23. Thijssen AY, Clemens CH, Vankerckhoven V, Goossens H, Jonkers DM, Masclee AA. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2016; 28 (1): 8-14. doi: 10.1097/ MEG.0000000000000484.

  24. Alamoudi NM, Almabadi ES, El Ashiry EA, El Derwi DA. Effect of probiotic Lactobacillus reuteri on salivary cariogenic bacterial counts among groups of preschool children in Jeddah, Saudi Arabia: A randomized clinical trial. J Clin Pediatr Dent 2018; 42 (5): 331-338. doi: 10.17796/1053-4625-42.5.2.

  25. Maragkoudaki M, Chouliaras G, Moutafi A, Thomas A, Orfanakou A, Papadopoulou A. Efficacy of an oral rehydration solution enriched with Lactobacillus reuteri DSM 17938 and zinc in the management of acute diarrhoea in infants: A randomized, double-blind, placebo-controlled trial. Nutrients 2018; 10 (9). doi: 10.3390/nu10091189.

  26. Indrio F, Riezzo G, Giordano P, Ficarella M, Miolla M, Martini S, et al. Effect of a partially hydrolysed whey infant formula supplemented with starch and Lactobacillus reuteri DSM 17938 on regurgitation and gastric motility. Nutrients 2017; 9 (11): 1181. doi: 10.3390/nu9111181.

  27. Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, et al. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS ONE 2017; 12 (10): e0185177. doi: 10.1371/journal.pone.0185177.

  28. Fatheree NY, Liu Y, Taylor CM, Hoang TK, Cai C, Rahbar MH, et al. Lactobacillus reuteri for infants with colic: a doubleblind, placebo-controlled, randomized clinical trial. J Pediatrics 2017; 191: 170-178. doi: 10.1016/j.jpeds.2017.07.036.

  29. Savino F, Garro M, Montanari P, Galliano I, Bergallo M. Crying time and RORγ/FOXP3 expression in Lactobacillus reuteri DSM17938-treated infants with colic: A randomized trial. J Pediatrics 2017; 192: 171-177. doi: 10.1016/j. jpeds.2017.08.062.

  30. Indrio F, Riezzo G, Tafuri S, Ficarella M, Carlucci B, Bisceglia M, et al. Probiotic supplementation in preterm: Feeding intolerance and hospital cost. Nutrients 2017; 9 (9): 965. doi: 10.3390/nu9090965.

  31. Maragkoudaki M, Chouliaras G, Orel R, Horvath A, Szajewska H y Papadopoulou A. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatr 2017; 106 (11): 1857-1862. doi: 10.1111/apa.13992.

  32. Mobini R, Tremaroli V, Ståhlman M, Karlsson F, Levin M, Ljungberg M. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab 2017; 19 (4): 579- 589. doi: 10.1111/dom.12861.

  33. Jadrešin O, Hojsak I, Mišak Z, Kekez AJ, Trbojević T, Ivković L, et al. Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT Study. J Pediatr Gastroenterol Nutr 2017; 64 (6): 925-929. doi: 10.1097/ MPG.0000000000001478.

  34. Miraglia Del Giudice M, Maiello N, Allegorico A, Iavarazzo L, Capasso M, Capristo C, et al. Lactobacillus reuteri DSM 17938 plus vitamin D3 as ancillary treatment in allergic children with asthma. Ann Allergy Asthma Immunol 2016; 117 (6): 710-712. doi: 10.1016/j.anai.2016.09.004.

  35. Schlagenhauf U, Jakob L, Eigenthaler M, Segerer S, Jockel- Schneider Y, Rehn M. Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT. J Clin Periodontol 2016; 43 (11): 948-954. doi: 10.1111/jcpe.12606.

  36. Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebocontrolled trial. J Pediatr 2016; 174: 160-164.e1. doi: 10.1016/j.jpeds.2016.04.003.

  37. Ferolla SM, Couto CA, Costa-Silva L, Armiliato GN, Pereira CA, Martins FS, et al. Beneficial effect of symbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis. Nutrients 2016; 8 (7). doi: 10.3390/nu8070397.

  38. Zhai Q, Liu Y, Wang C, Zhao J, Zhang H, Tian F, et al. Increased cadmium excretion due to oral administration of Lactobacillus plantarum strains by regulating enterohepatic circulation in mice. Agric Food Chem 2019; 67: 14: 3956-3965.

  39. Costabile A, Buttarazzi I, Kolida S, Quercia S, Baldini J, Swann JR, et al. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLoS ONE 2017; 12 (12). doi: 10.1371/journal.pone.0187964.

  40. Prakoeswa CRS, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Beneficial Microbes 2017; 8 (5): 833-840.

  41. Olek A, Woynarowski M, Ahren I L, Kierkus J, Socha P, Larsson N, et al. Efficacy and Safety of Lactobacillus plantarum DSM 9843 in the prevention of antibiotic-associated gastrointestinal symptoms in children-randomized, doubledblind, placebo-controlled study. J Pediatr 2017; 186: 82-86. doi: 10.1016/j.jpeds.2017.03.047.

  42. Feizollahzadeh S, Ghiasvand R, Rezaei A, Khanahmad H, Sadeghi A, Hariri M. Effect of probiotic soy milk on serum levels of adiponectin, inflammatory mediators, lipid profile, and fasting blood glucose among patients with type II diabetes mellitus. Probiotics Antimicrob Proteins 2016; 9 (1): 41-47. doi: 10.1007/s12602-016-9233-y.

  43. Harima-Mizusawa N, Kano M, Nozaki D, Nonaka C, Miyazaki K, Enomoto T. Citrus juice fermented with Lactobacillus plantarum YIT 0132 alleviates symptoms of perennial allergic rhinitis in a double-blind, placebo-controlled trial. Benef Microbes 2016; 7 (5): 649-658. doi: 10.3920/BM2016.0003.

  44. Hong-Chau TT, Chau NNM, Hoang-Le NT, The HC, Voong- Vinh P, To NTN, et al. A double blind, randomized, placebo-controlled trial of Lactobacillus acidophilus for the treatment of acute watery diarrhea in Vietnamese children. Pediatr Infect Dis J 2018; 37 (1): 35-42. doi: 10.1097/ INF.0000000000001712.

  45. Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, et al. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22 (48): 10631-10642. doi:10.3748/ wjg.v22.i48.10631.

  46. Pakdaman MN, Udani JK, Molina JP, Shahani M. The effects of the DDS-1 strain of Lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial. Nutr J 2016; 15 (1): 56. doi: 10.1186/s12937-016-0172-y.

  47. Ohsawa K, Nakamura F, Uchida N, Mizuno S, Yokogoshi H. Lactobacillus helveticus-fermented milk containing lactononadecapeptide (NIPPLTQTPVVVPPFLQPE) improves cognitive function in healthy middle-aged adults: a randomised, double- blind, placebo-controlled trial. Int J Food Sci Nutr 2017; 69 (3): 369-376. doi: 10.1080/09637486.2017.1365824.

  48. Michalickova D, Minic R, Dikic N, Andjelkovic M, Kostic- Vucicevic M, Stojmenovic T, et al. Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial. Appl Physiol Nutr Metab 2016; 41 (7): 782-9. doi: 10.1139/apnm-2015-0541.

  49. Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean JM, O’Connell KJ, et al. Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N Engl J Med 2018; 379 (21): 2002-2014. doi: 10.1056 / NEJMoa1802598.

  50. Morales A, Gandolfo A, Bravo J, Carvajal P, Silva N, Godoy C. Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 9-month follow-up. J Appl Oral Sci 2018; 26: e20170075. doi: 10.1590/1678-7757-2017-0075.

  51. Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PB. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infect Dis 2018; 18 (1): 13. doi: 10.1186/s12879-017-2938-z.

  52. Dongol Singh S, Klobassa DS, Resch B, Urlesberger B, Shrestha RP. Placebo controlled introduction of prophylactic supplementation of probiotics to decrease the incidence of necrotizing enterocolitis at Dhulikhel Hospital in Nepal. Kathmandu Univ Med J 2017; 15 (60): 319-323.

  53. Slykerman RF, Hood F, Wickens K, Thompson JMD, Barthow C, Murphy R, et al. Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine 2017; 24: 159-165. doi: 10.1016/j. ebiom.2017.09.013.

  54. Esposito C, Roberti A, Turrá F, Cerulo M, Severino G, Settimi A, Escolino M. Frequency of antibiotic-associated diarrhea and related complications in pediatric patients who underwent hypospadias repair: A comparative study using probiotics vs placebo. Probiotics Antimicrob Proteins 2017; 10 (2): 323-328. doi: 10.1007/s12602-017-9324-4.

  55. Cabana MD, McKean M, Caughey AB, Fong L, Lynch S, Wong A, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics 2017; 140 (3): e2013000. doi: 10.1542/ peds.2016-3000.

  56. Wickens KL, Barthow CA, Murphy R, Abels PR, Maude RM, Stone PR, et al. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. Br J Nutr 2017; 117: 804-813. doi: 10.1017/ S0007114517000289.

  57. Sanchez M, Darimont C, Panahi S, Drapeau V, Marette A, Taylor VH, et al. Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients 2017; 15: 9 (3). doi: 10.3390/nu9030284.

  58. Gorshein E, Wei C, Ambrosy S, Budney S, Vivas J, Shenkerman A, et al. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation. Clin Transplant 2017; 31 (5). doi: 10.1111/ctr.12947.

  59. Korpela K, Salonen A, Virta LJ, Kumpu M, Kekkonen RA, de Vos WM. Lactobacillus rhamnosus GG intake modifies preschool children’s intestinal microbiota, alleviates penicillin-associated changes, and reduces antibiotic use. PLoS One 2016; 11 (4): e0154012. doi: 10.1371/journal. pone.0154012.

  60. Tapiovaara L, Kumpu M, Mäkivuokko H, Waris M, Korpela R, Pitkäranta A, Winther B. Human rhinovirus in experimental infection after peroral Lactobacillus rhamnosus GG consumption, a pilot study. Int Forum Allergy Rhinol 2016; 6 (8): 848-53. doi: 10.1002/alr.21748.

  61. Rodríguez G, Ruiz B, Faleiros S, Vistoso A, Marró ML, Sánchez J, et al. Probiotic compared with standard milk for high-caries children: a cluster randomized trial. J Dent Res 2016; 95 (4): 402-7. doi: 10.1177/0022034515623935.

  62. Pahumunto N, Piwat S, Chankanka O, Akkarachaneeyakorn N, Rangsitsathian K. Teanpaisan R. Reducing mutans streptococci and caries development by Lactobacillus paracasei SD1 in preschool children: a randomized placebocontrolled trial. Acta Odontol Scand 2018; 76 (5): 331-337. doi: 10.1080/00016357.2018.1453083.

  63. Pu F, Guo Y, Li M, Zhu H, Wang S, Shen S, et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial. Clin Interv Aging 2017; 12: 1223-1231. doi: 10.2147/CIA.S141518.

  64. Reygagne P, Bastien P, Couavoux MP, Philippe D, Renouf M, Castiel-Higounenc I, et al. The positive benefit of Lactobacillus paracasei NCC2461 ST11 in healthy volunteers with moderate to severe dandruff. Benef Microbes 2017; 8 (5): 671-680. doi: 10.3920/BM2016.0144.

  65. Corsello G, Carta M, Marinello R, Picca M, De Marco G, Micillo M, et al. Preventive effect of cow’s milk fermented with Lactobacillus paracasei CBA L74 on common infectious diseases in children: A multicenter randomized controlled trial. Nutrients 2017; 9 (7): e669. doi: 10.3390/nu9070669.

  66. Maretti C, Cavallini G. The association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot study. Andrology 2017; 5 (3): 439-444. doi: 10.1111/andr.12336.

  67. Maruyama M, Abe R, Shimono T, Iwabuchi N, Abe F, Xiao JZ. The effects of non-viable Lactobacillus on immune function in the elderly: a randomised, double-blind, placebo-controlled study. Int J Food Sci Nutr 2016; 67 (1): 67-73. doi: 10.3109/09637486.2015.1126564.

  68. Alberda C, Marcushamer S, Hewer T, Journault N, Kutsogiannis D. Feasibility of a Lactobacillus casei drink in the intensive care unit for prevention of antibiotic associated diarrhea and Clostridium difficile. Nutrients 2018; 10 (5): 539. doi: 10.3390/nu10050539.

  69. De Sanctis V, Belgioia L, Cante D, La Porta MR, Caspiani O, Guarnaccia R, Argenone A, Muto P, Musio D, et al. Lactobacillus brevis CD2 for prevention of oral mucositis in patients with head and neck tumors: a multicentric randomized study. Anticancer Res 2019; 39: 1935-1942. doi: 10.21873/anticanres.13303.

  70. Mohseni AH, Taghinezhad SS, Keyvani H, Ghobadi N. Comparison of Acyclovir and Multistrain Lactobacillus brevis in women with recurrent genital herpes infections: a double-blind, randomized, controlled study. Probiotics Antimicrob Proteins 2018; 10 (4): 740-747. doi: 10.1007/ s12602-017-9320-8.

  71. Fuke N, Aizaea K, Suganuma H, Takagi T, Naito Y. Effect of combined consumption of Lactobcillus brevis KB290 and β-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallelgroup trial. Int J Food Sci Nutr 2017; 68 (8): 973-986. doi: 10.1080/09637486.2017.1311843.

  72. Fernández L, Cárdenas N, Arroyo R, Manzano S, Jiménez E, Martín V, Rodríguez JM. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy. Clin Infect Dis 2016; 62 (5): 568-573. doi: 10.1093/cid/civ974.

  73. Bohbot JM, Daraï E, Bretelle F, Brami G, Daniel C, Cardot JM. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod 2017; 47 (2): 81-86. doi: 10.1016/j.jogoh.2017.11.005.

  74. Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. J Med Food 2018; 21 (5): 454-461. doi: 10.1089/jmf.2017.3937.

  75. Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/ or gout: A randomised, double-blind, placebo-controlled study. Mod Rheumatol 2019; 29 (1): 146-150. doi: 10.1080/14397595.2018.1442183.

  76. Ohtsu T, Takagi A, Uemura N, Inoue K, Sekino H, Kawashima, et al. The ameliorating effect of Lactobacillus gasseri OLL2716 on functional dyspepsia in helicobacter pylori -uninfected individuals: a randomized controlled study. Digestion 2017; 96 (2): 92-102. doi: 10.1159/000479000.

  77. Suzuki T, Masui A, Nakamura J, Shiozawa H, Aoki J, Nakae H, et al. Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: a prospective, randomized, double-blind, placebo-controlled trial. Digestion 2017; 95 (1): 49-54. doi: 10.1159/000452361.

  78. Nobutani K, Sawada D, Fujiwara S, Kuwano Y, Nishida K, Nakayama J, et al. The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. J Appl Microbiol 2017; 122 (1): 212-224. doi: 10.1111/jam.13329.

  79. Bahmani F, Tajadadi-Ebrahimi M, Kolahdooz F, Mazouchi M, Hadaegh H, Jamal AS, et al. The consumption of synbiotic bread containing Lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 Diabetes Mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 2016; 35 (6): 506- 513. doi: 10.1080/07315724.2015.1032443.

  80. Kullisaar T, Zilmer K, Salum T, Rehema A, Zilmer M. The use of probiotic Lactobacillus fermentum ME-3 containing Reg’Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study. Nutr J 2016; 15 (1): 93. https://doi.org/10.1186/s12937-016-0213-6.

  81. Russo R, Superti F, Karadja E, De Seta F. Randomised clinical trial in women with recurrent vulvovaginal candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses 2019; 62 (4): 328-335. doi: 10.1111/myc.12883.

  82. Gerasimov S, Gantzel J, Dementieva N, Schevchenko O, Tsitsura O, Guta N, et al. Role of Lactobacillus rhamnosus (FloraActive ™) 19070-2 and Lactobacillus reuteri (FloraActive™) 12246 in infant colic: a randomized dietary study. Nutrients 2018; 10 (12): pii: E1975. doi: 10.3390/nu10121975.

  83. Freedman SB, Williamson-Urquhart S, Farion KJ, Gouin S, Willan AR, Poonai N, et al. Multicenter trial of a combination probiotic for children with gastroenteritis. N Engl J Med 2018; 379 (21): 2015-2026. doi: 10.1056/ NEJMoa1802597.

  84. Keller MK, Brandsborg E, Holmstrom K, Twetman S. Effect of tablets containing probiotic candidate strains on gingival inflammation and composition of the salivary microbiome: a randomised controlled trial. Benef Microbes 2017; 9 (3): 487-494. doi: 10.3920/BM2017.0104.

  85. Yuriko T, Ishikawa KH, Mayer MPA, Saad SMI, Nakamae AEM, et al. Cheese supplemented with probiotics reduced the Candida levels in denture wearers—RCT. Oral Diseases 2017; 23 (7): 919-925. doi: 10.1111/odi.12669.

  86. Salomão MC, Heluany-Filho MA, Menegueti MG, Kraker ME, Martinez R, Bellissimo-Rodrigues F. A randomized clinical trial on the effectiveness of a symbiotic product to decolonize patients harboring multidrug-resistant Gramnegative bacilli. Rev Soc Bras Med Trop 2016; 49 (5): 559- 566. doi: 10.1590/0037-8682-0233-2016.

  87. Lee CY, Shih HC, Yu MC, Lee MY, Chang YL, Lai YY, et al. Evaluation of the potential inhibitory activity of a combination of L. acidophilus, L. rhamnosus and L. sporogenes on Helicobacter pylori: A randomized double-blind placebocontrolled clinical trial. Chin J Integr Med 2017; 23 (3): 176-182. doi: 10.1007/s11655-016-2531-0.




2020     |     www.medigraphic.com